Fingolimod-associated macular edema controlled with nepafenac non-steroidal anti-inflammatory opthalmologic applications

Fingolimod, an immunomodulatory agent, is used for the treatment of relapsing –remitting multiple sclerosis (RRMS). Fingolimod-associated macular edema (FAME) is a known complication with an incidence of 0.4%. ...

Source: Clinical and Molecular Allergy - March 12, 2020 Category: Allergy & Immunology Authors: Rachel Husmann, John B. Davies, Malik Ghannam, Brent Berry and Praful Kelkar Tags: Case Report Source Type: research